home / stock / cybn:cc / cybn:cc news


CYBN:CC News and Press, CYBIN INC. From 04/06/22

Stock Information

Company Name: CYBIN INC.
Stock Symbol: CYBN:CC
Market: AQNC

Menu

CYBN:CC CYBN:CC Quote CYBN:CC Short CYBN:CC News CYBN:CC Articles CYBN:CC Message Board
Get CYBN:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

CYBN:CC - Cybin to Present at the Benzinga Psychedelics Capital Conference in Miami on April 19, 2022

Cybin Inc. ( NEO:CYBN ) (NYSE American:CYBN) (“ Cybin ” or the “ Company ”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics ™ ” is pleased to announce that Doug Drysdale, Cybin’...

CYBN:CC - Ibogaine Blocks Reward Pathways in Alcohol-Dependent Mice

New research has found that ibogaine blocks some of the abuse-related effects of alcohol in mice. Ibogaine is a natural product extracted from the Tabernanthe iboga plant. It is commonly used during religious ceremonies in the form of tea and is extracted from the plant’s root, ba...

CYBN:CC - Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Begins Recruitment for Study Measuring Ketamine's Psychedelic Effect

Cybin-sponsored study will use Kernel Flow, Kernel’s quantitative neuroimaging. Company hopes to learn more about impact ketamine has on brain activity, overall mental well-being. Study results may lead to future studies supporting CYBN’s mission to develop psychedelics ...

CYBN:CC - Timing of Food Intake Impacts Mental Health, Study Says

New research has discovered that the time at which an individual consumes food may impact their mental health. Focusing on what you eat is important for your overall health, but did you know that paying some attention to when you eat may also be good for your mental health? Research has ...

CYBN:CC - InvestorNewsBreaks - Cybin Inc.'s (NYSE American: CYBN) (NEO: CYBN) Adelia Therapeutics Inc. Achieves New Milestone

Cybin (NYSE American: CYBN) (NEO: CYBN) , a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that Adelia Therapeutics, a wholly controlled subsidiary of Cybin, has achieved the milestone identified as Year 1, Q2 (iv) as conte...

CYBN:CC - Four Psychedelics Movies to Watch

Interest in psychedelic substances has grown significantly these last couple of years as studies unearth more evidence on their benefits and numerous uses. That interest isn’t just confined to uses and benefits; attention has also been paid to psychedelic media. If you’re inter...

CYBN:CC - InvestorNewsBreaks - Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Commencement of Kernel Flow(R) Feasibility Study, Marking Exciting Moment for Psychedelic Drug Development

Cybin (NYSE American: CYBN) (NEO: CYBN) , a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that the first visit has been conducted in a Cybin-sponsored feasibility study. The study will focus on evaluating Kernel’s q...

CYBN:CC - Cybin Announces Initiation of Kernel Flow® Feasibility Study Measuring Psychedelic Effects on the Brain

Cybin Inc. ( NEO:CYBN ) (NYSE American:CYBN) ( Cybin or the Company ), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics TM ”, today announced that the first study visit has been conducted in a Cybin-sponsored feasibility ...

CYBN:CC - Another City in Michigan Approves Measure to Decriminalize Psychedelics

Last week, the city council of Hazel Park, Michigan, moved to decriminalize psychedelic substances , including ibogaine and psilocybin. Before the city council unanimously passed the measure, the measure’s sponsor, Councilmember Luke Londo, revealed that he’d personally used p...

CYBN:CC - New Research Reveals How Psychedelics Are Helping Combat Mental Illness

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 29, 2022 – Mental health cases are continuing to rise and are taking a serious toll on the healthcare system. Luckily, psychedelics like DMT, psilocybin, MDMA, and LSD are bein...

Previous 10 Next 10